Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Results Of Postal Ballot (Including E-Voting) Under Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 We refer to our letter dated February 21, 2017 enclosing the Notice along with Explanatory Statement for seeking the consent of the Members for matters set forth in the Postal Ballot Notice. Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the voting results of the said Postal Ballot and would like to inform you that the Resolution set forth in the Postal Ballot Notice...
24-03-2017
Bigul

Clarifies on News item

 With reference to news flashed on ET Now dated March 01, 2017. "US FDA grants priority review for SD-809", Neuland Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.
01-03-2017
Bigul

Clarification sought from Neuland Laboratories Ltd

 The Exchange has sought clarification from Neuland Laboratories Ltd on March 01, 2017 with reference to news flashed on ET Now dated March 01, 2017. "US FDA grants priority review for SD-809"The reply is awaited.
01-03-2017
Bigul

Publication of postal ballot notice

 Neuland Laboratories Ltd has submitted to BSE a copy of newspaper publication on February 22, 2017, of the Advertisement of Notice of Postal Ballot conducted to seek approval of the shareholders of the company by way of an Ordinary Resolution under Regulation 23 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ("LODR" Regulations) by way of postal ballot / e-voting.
22-02-2017
Bigul

Notice of Postal Ballot

 Neuland Laboratories Ltd has submitted to BSE a copy of Notice of Postal Ballot.
21-02-2017
Bigul

Results Press Release for December 31, 2016

 Neuland Laboratories Ltd has informed BSE about : 1. Result Press Release for the period ended December 31, 2016
10-02-2017
Bigul

Outcome of Board Meeting

 Neuland Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 10, 2017, has approval to the following businesses:1. Considered and approved draft Postal Ballot Notice to approve Related Party Transactions.2. Approved resignation of Mr. Anil Kumar, Chief Financial Officer (Key Managerial Personnel) of the Company, who would be relieved from the services of the Company from the...
10-02-2017
Bigul

Standalone Financial Results, Limited Review Report for December 31, 2016

 Neuland Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 2016
10-02-2017
Bigul

Q3 FY 2017 Earnings Call details

 Neuland Laboratories Ltd has submitted to BSE a copy of the Q3 FY 2017 Earnings Call details.
06-02-2017
Bigul

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016

 Neuland Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
18-01-2017
Next Page
Close

Let's Open Free Demat Account